Clinical trials

  • CAFFEINE for Alzheimer's disease
  • TARLATAMAB for Extensive-stage small cell lung cancer
  • GEFURULIMAB for Generalized myasthenia gravis (acetylcholine receptor antibody positive)
  • MEROPENEM TRIHYDRATE for Sepsis
  • Deflazacort for Laminopathies | LMNA-related congenital muscular dystrophy (L-CMD) | Emery-Dreifuss muscular dystrophy (EDMD2)
  • LENACAPAVIR for Human Immunodeficiency Virus (HIV-1) infection
  • ABBV-319 for Systemic lupus erythematosus | Sjögren's syndrome
  • REVUMENIB for Acute myeloid leukemia | Acute myeloid leukemia with NPM1 mutation | Acute myeloid leukemia with KMT2A rearrangement
  • TICAGRELOR for Coronary artery disease
  • RILZABRUTINIB for Sickle cell disease
  • SUNVOZERTINIB for Non-small cell lung cancer
  • TALQUETAMAB for Multiple myeloma